Name: UMIN ID:
Unique ID issued by UMIN | UMIN000005041 |
---|---|
Receipt number | R000005993 |
Scientific Title | The Feasibility Study of Adjuvant Chemotherapy with TS-1+Carboplatin followed by TS-1 maintenace in Patients with Completely Resected Stage II-IIIA Non-Small-Cell Lung Cancer |
Date of disclosure of the study information | 2011/02/07 |
Last modified on | 2019/08/15 16:52:12 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2011/02/06 22:42:53 | ||
2 | Update | 2019/08/15 15:15:33 | UMIN ID1 UMIN ID2 UMIN ID3 |
|
3 | Update | 2019/08/15 15:43:20 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Organization Zip code Address Address TEL Last name of contact person Last name of contact person Division name Division name Zip code Address Address Name of person sending information Name of person sending information Organization Organization Address TEL Name of primary person or sponsor Organization Post marketing survey by drug manufacture etc., specified by Japanese law. Organization1 Tel1 Email1 Organization Organization Address Address Tel |
|
4 | Update | 2019/08/15 15:59:40 | Recruitment status Date of IRB Anticipated trial start date Last follow-up date |
|
5 | Update | 2019/08/15 16:11:44 | URL releasing protocol Publication of results URL related to results and publications Number of participants that the trial has enrolled Results Results Results date posted Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
|
6 | Update | 2019/08/15 16:51:38 | Date of closure to data entry |
|
7 | Update | 2019/08/15 16:52:12 | Date of closure to data entry |